CORRESP 1 filename1.htm

September 5, 2018
 
 
Re: AC Immune SA
Registration Statement on Form F-3
Filed on August 24, 2018
Registration No. 333-227016

 

 

 

Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549

 

Ladies and Gentlemen:

 

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Daylight Time on September 7, 2018 or as soon thereafter as is practicable.

 

Sincerely,

 

 

AC Immune SA
 
 
By: /s/Andrea Pfeifer
  Name: Andrea Pfeifer
  Title:   Chief Executive Officer
   
   
By: /s/Joerg Hornstein
  Name: Joerg Hornstein
  Title:   Chief Financial Officer

 

 

Via EDGAR